Tuesday 3 November 2015

• 09:30 - The cannabis derivative cannabidiol in the treatment of schizophrenia: results of the first placebo-controlled clinical trial
  Dr Phil Robson (Honorary Senior Research Fellow, University of Oxford)
  Psychiatry Seminars